HIV heart inflammation is mediated by HIV infected myeloid cells, HIV-tat secretion, and aberrant function of Connexin43-containing channels

1. Feinstein, M. J. et al. Characteristics, prevention, and management of cardiovascular disease in people living with HIV: A scientific statement from the American Heart Association. Circulation 140, e98-e124. https://doi.org/10.1161/cir.0000000000000695 (2019).

2. Sinha, A. & Feinstein, M. Epidemiology, pathophysiology, and prevention of heart failure in people with HIV. Prog Cardiovasc. Dis. 63, 134–141. https://doi.org/10.1016/j.pcad.2020.01.002 (2020).

   Google Scholar 

3. Smit, M. et al. Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect. Dis. 15, 810–818. https://doi.org/10.1016/s1473-3099(15)00056 (2015).

   Google Scholar 

4. Freiberg, M. S. et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern. Med. 173, 614–622. https://doi.org/10.1001/jamainternmed.2013.3728 (2013).

   Google Scholar 

5. Freiberg, M. S. et al. Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort Study. JAMA Cardiol. 2, 536–546. https://doi.org/10.1001/jamacardio.2017.0264 (2017).

   Google Scholar 

6. Feinstein, M. J. et al. Patterns of Cardiovascular Mortality for HIV-Infected Adults in the United States: 1999 to 2013. Am. J. Cardiol. 117, 214–220. https://doi.org/10.1016/j.amjcard.2015.10.030 (2016).

   Google Scholar 

7. Twu, C. et al. Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathways. Proc. Natl. Acad. Sci. U S A. 99, 14386–14391. https://doi.org/10.1073/pnas.212327899 (2002).

   Google Scholar 

8. Fiala, M. et al. HIV-1 induces cardiomyopathyby cardiomyocyte invasion and gp120, Tat, and cytokine apoptotic signaling. Cardiovasc. Toxicol. 4, 97–107. https://doi.org/10.1385/ct:4:2:097 (2004).

   Google Scholar 

9. Es-Salah-Lamoureux, Z. et al. HIV-Tat induces a decrease in I(Kr) and I(Ks)via reduction in phosphatidylinositol-(4,5)-bisphosphate availability. J. Mol. Cell. Cardiol. 99, 1–13. https://doi.org/10.1016/j.yjmcc.2016.08.022 (2016).

   Google Scholar 

10. Meng, Z. et al. HIV Protein Tat Induces Macrophage Dysfunction and Atherosclerosis Development in Low-Density Lipoprotein Receptor-Deficient Mice. Cardiovasc. Drugs Ther. https://doi.org/10.1007/s10557-021-07141-x (2021).

    Google Scholar 

11. Raidel, S. M. et al. Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage. Am. J. Physiol. Heart Circ. Physiol. 282, H1672–1678. https://doi.org/10.1152/ajpheart.00955.2001 (2002).

    Google Scholar 

12. Tahrir, F. G. et al. Dysregulation of mitochondrial bioenergetics and quality control by HIV-1 Tat in cardiomyocytes. J. Cell. Physiol. 233, 748–758. https://doi.org/10.1002/jcp.26002 (2018).

    Google Scholar 

13. Wang, T. et al. Increased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and Tat. Cardiovasc. Pathol. 24, 279–282. https://doi.org/10.1016/j.carpath.2015.07.001 (2015).

    Google Scholar 

14. Gao, R. et al. R5 HIV-1 gp120 Activates p38 MAPK to Induce Rat Cardiomyocyte Injury by the CCR5 Coreceptor. Pathobiology 86, 274–284. https://doi.org/10.1159/000502238 (2019).

    Google Scholar 

15. Schecter, A. D. et al. HIV envelope gp120 activates human arterial smooth muscle cells. Proc. Natl. Acad. Sci. U S A. 98, 10142–10147. https://doi.org/10.1073/pnas.181328798 (2001).

    Google Scholar 

16. Smit, M. et al. Cardiovascular Disease Prevention Policy in Human Immunodeficiency Virus: Recommendations From a Modeling Study. Clin. Infect. Dis. 66, 743–750. https://doi.org/10.1093/cid/cix858 (2018).

    Google Scholar 

17. Herskowitz, A. et al. Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection. Am. J. Cardiol. 71, 955–958. https://doi.org/10.1016/0002-9149(93)90913-w (1993).

    Google Scholar 

18. Coudray, N. et al. Left ventricular diastolic function in asymptomatic and symptomatic human immunodeficiency virus carriers: an echocardiographic study. Eur. Heart J. 16, 61–67. https://doi.org/10.1093/eurheartj/16.1.61 (1995).

    Google Scholar 

19. Barbaro, G., Di Lorenzo, G., Grisorio, B. & Barbarini, G. Cardiac involvement in the acquired immunodeficiency syndrome: a multicenter clinical-pathological study. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS Investigators. AIDS Res. Hum. Retroviruses. 14, 1071–1077. https://doi.org/10.1089/aid.1998.14.1071 (1998).

    Google Scholar 

20. Olalla, J. & Pombo, M. Sudden Cardiac Death and Myocardial Fibrosis in Persons with HIV. N Engl. J. Med. 385, e50. https://doi.org/10.1056/NEJMc2112481 (2021).

    Google Scholar 

21. Tseng, Z. H. et al. Sudden Cardiac Death and Myocardial Fibrosis, Determined by Autopsy, in Persons with HIV. N Engl. J. Med. 384, 2306–2316. https://doi.org/10.1056/NEJMoa1914279 (2021).

    Google Scholar 

22. Delmar, M. et al. Connexins and disease. Cold Spring Harb. Perspect. Biol. 10 https://doi.org/10.1101/cshperspect.a029348 (2018).

23. Lampe, P. D. & Lau, A. F. The effects of connexin phosphorylation on gap junctional communication. Int. J. Biochem. Cell. Biol. 36, 1171–1186. https://doi.org/10.1016/s1357-2725(03)00264-4 (2004).

    Google Scholar 

24. Iwasaki, Y. K., Nishida, K., Kato, T. & Nattel, S. Atrial fibrillation pathophysiology: implications for management. Circulation 124, 2264–2274. https://doi.org/10.1161/circulationaha.111.019893 (2011).

    Google Scholar 

25. Juneja, S. C., Barr, K. J., Enders, G. C. & Kidder, G. M. Defects in the germ line and gonads of mice lacking connexin43. Biol. Reprod. 60, 1263–1270. https://doi.org/10.1095/biolreprod60.5.1263 (1999).

    Google Scholar 

26. Maass, K. et al. Defective epidermal barrier in neonatal mice lacking the C-terminal region of connexin43. Mol. Biol. Cell. 15, 4597–4608. https://doi.org/10.1091/mbc.e04-04-0324 (2004).

    Google Scholar 

27. Reaume, A. G. et al. Cardiac malformation in neonatal mice lacking connexin43. Science 267, 1831–1834. https://doi.org/10.1126/science.7892609 (1995).

28. Guerrero, P. A. et al. Slow ventricular conduction in mice heterozygous for a connexin43 null mutation. J. Clin. Invest. 99, 1991–1998. https://doi.org/10.1172/jci119367 (1997).

    Google Scholar 

29. Vaidya, D. et al. Null mutation of connexin43 causes slow propagation of ventricular activation in the late stages of mouse embryonic development. Circ. Res. 88, 1196–1202. https://doi.org/10.1161/hh1101.091107 (2001).

    Google Scholar 

30. Retamal, M. A., Schalper, K. A., Shoji, K. F., Bennett, M. V. & Sáez, J. C. Opening of connexin 43 hemichannels is increased by lowering intracellular redox potential. Proc. Natl. Acad. Sci. U S A. 104, 8322–8327. https://doi.org/10.1073/pnas.0702456104 (2007).

    Google Scholar 

31. Himelman, E. et al. Prevention of connexin-43 remodeling protects against Duchenne muscular dystrophy cardiomyopathy. J. Clin. Invest. 130, 1713–1727. https://doi.org/10.1172/jci128190 (2020).

    Google Scholar 

32. De Smet, M. A. et al. Cx43 hemichannel microdomain signaling at the intercalated disc enhances cardiac excitability. J. Clin. Invest. 131 https://doi.org/10.1172/jci137752 (2021).

33. Abudan, A. A. et al. Burden of arrhythmia in hospitalized HIV patients. Clin. Cardiol. 44, 66–77. https://doi.org/10.1002/clc.23506 (2021).

    Google Scholar 

34. Brouillette, J., Cyr, S. & Fiset, C. Mechanisms of Arrhythmia and Sudden Cardiac Death in Patients With HIV Infection. Can. J. Cardiol. 35, 310–319. https://doi.org/10.1016/j.cjca.2018.12.015 (2019).

    Google Scholar 

35. Prevedel, L., Morocho, C., Bennett, M. V. L. & Eugenin, E. A. HIV-Associated Cardiovascular Disease: Role of Connexin 43. Am. J. Pathol. 187, 1960–1970. https://doi.org/10.1016/j.ajpath.2017.05.011 (2017).

    Google Scholar 

36. Araujo, P. A., Munoz, M., Quan, J. & Contreras, J. E. Connexin-43 remodelling and arrhythmias: hemichannels as key drivers of cardiac dysfunction. J. Physiol. https://doi.org/10.1113/JP288091 (2025).

    Google Scholar 

37. Jagielnicki, M., Kucharska, I., Bennett, B. C., Harris, A. L. & Yeager, M. Connexin gap junction channels and hemichannels: Insights from high-resolution structures. Biology (Basel) 13. https://doi.org/10.3390/biology13050298 (2024).

38. Donoso, M. et al. Identification, quantification, and characterization of HIV-1 reservoirs in the human brain. Cells 11. (2022). https://doi.org/10.3390/cells11152379

39. Berman, J. W. et al. HIV-tat alters Connexin43 expression and trafficking in human astrocytes: role in NeuroAIDS. J. Neuroinflamm. 13, 54. https://doi.org/10.1186/s12974-016-0510-1 (2016).

    Google Scholar 

40. Hanson, S. W. et al. A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021. medRxiv https://doi.org/10.1101/2022.05.26.22275532 (2022).

    Google Scholar 

41. Paige, S. L., Plonowska, K., Xu, A. & Wu, S. M. Molecular regulation of cardiomyocyte differentiation. Circ. Res. 116, 341–353. https://doi.org/10.1161/CIRCRESAHA.116.302752 (2015).

    Google Scholar 

42. Luna-Zurita, L. et al. Complex Interdependence Regulates Heterotypic Transcription Factor Distribution and Coordinates Cardiogenesis. Cell 164, 999–1014. https://doi.org/10.1016/j.cell.2016.01.004 (2016).

    Google Scholar 

43. Moskowitz, I. P. et al. A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system development. Cell 129, 1365–1376. https://doi.org/10.1016/j.cell.2007.04.036 (2007).

    Google Scholar 

44. Krogh, K. A., Lyddon, E. & Thayer, S. A. HIV-1 Tat activates a RhoA signaling pathway to reduce NMDA-evoked calcium responses in hippocampal neurons via an actin-dependent mechanism. J. Neurochem. 132, 354–366. https://doi.org/10.1111/jnc.12936 (2015).

    Google Scholar 

45. Ajasin, D. & Eugenin, E. A. HIV-1 Tat: Role in Bystander Toxicity. Front. Cell. Infect. Microbiol. 10, 61. https://doi.org/10.3389/fcimb.2020.00061 (2020).

    Google Scholar 

46. Melo, T. G., Almeida, D. S., Meirelles, M. N. & Pereira, M. C. Disarray of sarcomeric alpha-actinin in cardiomyocytes infected by Trypanosoma cruzi. Parasitology 133, 171–178. https://doi.org/10.1017/S0031182006000011 (2006).

    Google Scholar 

47. Berman, J. W. et al. HIV-tat alters Connexin43 expression and trafficking in human astrocytes: role in NeuroAIDS. J. Neuroinflamm. 13 https://doi.org/10.1186/s12974-016-0510-1 (2016).

48. Hooper, J., Poynter, S. J. & DeWitte-Orr, S. J. Identifying connexin expression and determining gap junction intercellular communication in rainbow trout cells. Vitro Cell. Dev. Biol. Anim. 53, 406–416. https://doi.org/10.1007/s11626-017-0138-1 (2017).

    Google Scholar 

49. Song, E. K. et al. Connexin-43 hemichannels mediate cyclic ADP-ribose generation and its Ca2+-mobilizing activity by NAD+/cyclic ADP-ribose transport. J. Biol. Chem. 286, 44480–44490. https://doi.org/10.1074/jbc.M111.307645 (2011).

    Google Scholar 

50. Zhao, D. et al. Connexin hemichannels with prostaglandin release in anabolic function of bone to mechanical loading. Elife 11 https://doi.org/10.7554/eLife.74365 (2022).

51. Dosch, M. et al. Connexin-43-dependent ATP release mediates macrophage activation during sepsis. Elife 8. https://doi.org/10.7554/eLife.42670 (2019).

52. Squecco, R. et al. Sphingosine 1-phosphate induces myoblast differentiation through Cx43 protein expression: a role for a gap junction-dependent and -independent function. Mol. Biol. Cell. 17, 4896–4910. https://doi.org/10.1091/mbc.e06-03-0243 (2006).

    Google Scholar 

53. Orellana, J. A. et al. ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels. J. Neurochem. 118, 826–840. https://doi.org/10.1111/j.1471-4159.2011.07210.x (2011).

    Google Scholar 

54. Monsuez, J. J. & Lopez-Sublet, M. Prevention of Sudden Cardiac Death in Persons Living with HIV Infection. Curr. HIV Res. 20, 2–6. https://doi.org/10.2174/1570162X19666210922154011 (2022).

    Google Scholar 

55. Triant, V. A. Cardiovascular disease and HIV infection. Curr. HIV/AIDS. Rep. 10, 199–206. https://doi.org/10.1007/s11904-013-0168-6 (2013).

    Google Scholar 

56. Barbaro, G. & Lipshultz, S. E. Pathogenesis of HIV-associated cardiomyopathy. Ann. N Y Acad. Sci. 946, 57–81. https://doi.org/10.1111/j.1749-6632.2001.tb03903.x (2001).

    Google Scholar 

57. Walker, J. A. et al. Anti-α4 integrin antibody blocks monocyte/macrophage traffic to the heart and decreases cardiac pathology in a SIV infection model of AIDS. J. Am. Heart Assoc. 4 https://doi.org/10.1161/jaha.115.001932 (2015).

58. Cobos-Jiménez, V., Booiman, T., Hamann, J. & Kootstra, N. A. Macrophages and HIV-1. Curr. Opin. HIV AIDS. 6, 385–390. https://doi.org/10.1097/COH.0b013e3283497203 (2011).

    Google Scholar 

59. Dick, S. A. et al. Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction. Nat. Immunol. 20, 29–39. https://doi.org/10.1038/s41590-018-0272-2 (2019).

    Google Scholar 

60. Sager, H. B. et al. Proliferation and Recruitment Contribute to Myocardial Macrophage Expansion in Chronic Heart Failure. Circ. Res. 119, 853–864. https://doi.org/10.1161/circresaha.116.309001 (2016).

    Google Scholar 

61. Sattentau, Q. J. & Stevenson, M. Macrophages and HIV-1: An Unhealthy Constellation. Cell. Host Microbe. 19, 304–310. https://doi.org/10.1016/j.chom.2016.02.013 (2016).

    Google Scholar 

62. Taylor, R. A. et al. PET/CT targeted tissue sampling reveals virus specific dIgA can alter the distribution and localization of HIV after rectal exposure. PLoS Pathog. 17, e1009632. https://doi.org/10.1371/journal.ppat.1009632 (2021).

    Google Scholar 

63. Dash, P. K. et al. HIV-1-Associated Left Ventricular Cardiac Dysfunction in Humanized Mice. Sci. Rep. 10, 9746. https://doi.org/10.1038/s41598-020-65943-9 (2020).

    Google Scholar 

64. Herskowitz, A. et al. Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus. J. Am. Coll. Cardiol. 24, 1025–1032. https://doi.org/10.1016/0735-1097(94)90865-6 (1994).

    Google Scholar 

65. Rajaratnam, A. et al. Right ventricular load and contractility in HIV-associated pulmonary hypertension. PLoS One. 16, e0243274. https://doi.org/10.1371/journal.pone.0243274 (2021).

    Google Scholar 

66. Hamadou, B. et al. Echocardiographic and electrocardiographic abnormalities in adults living with human immunodeficiency virus: a cross-sectional study in the Yaounde Central Hospital, Cameroon. Cardiovasc. Diagn. Ther. 7, 607–615. https://doi.org/10.21037/cdt.2017.10.12 (2017).

    Google Scholar 

67. Thiara, D. K. et al. Abnormal Myocardial Function Is Related to Myocardial Steatosis and Diffuse Myocardial Fibrosis in HIV-Infected Adults. J. Infect. Dis. 212, 1544–1551. https://doi.org/10.1093/infdis/jiv274 (2015).

    Google Scholar 

68. Ntusi, N. A. B. & Ntsekhe, M. Human immunodeficiency virus-associated heart failure in sub-Saharan Africa: evolution in the epidemiology, pathophysiology, and clinical manifestations in the antiretroviral era. ESC Heart Fail. 3, 158–167. https://doi.org/10.1002/ehf2.12087 (2016).

    Google Scholar 

69. Grody, W. W., Cheng, L. & Lewis, W. Infection of the heart by the human immunodeficiency virus. Am. J. Cardiol. 66, 203–206. https://doi.org/10.1016/0002-9149(90)90589-s (1990).

    Google Scholar 

70. Barbaro, G., Di Lorenzo, G., Grisorio, B. & Barbarini, G. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS. N Engl. J. Med. 339, 1093–1099. https://doi.org/10.1056/nejm199810153391601 (1998).

    Google Scholar 

71. Valdebenito, S., Audia, A., Bhat, K. P. L., Okafo, G. & Eugenin, E. A. Tunneling nanotubes mediate adaptation of glioblastoma cells to temozolomide and ionizing radiation treatment. iScience 23, 101450. https://doi.org/10.1016/j.isci.2020.101450 (2020).

72. Okafo, G., Prevedel, L. & Eugenin, E. Tunneling nanotubes (TNT) mediate long-range gap junctional communication: Implications for HIV cell to cell spread. Sci. Rep. 7, 16660. https://doi.org/10.1038/s41598-017-16600-1 (2017).

    Google Scholar 

73. Eugenin, E. A., Gaskill, P. J. & Berman, J. W. Tunneling nanotubes (TNT) are induced by HIV-infection of macrophages: a potential mechanism for intercellular HIV trafficking. Cell. Immunol. 254, 142–148. https://doi.org/10.1016/j.cellimm.2008.08.005 (2009).

    Google Scholar 

74. Eugenin, E. A. et al. Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular disease. Am. J. Pathol. 172, 1100–1111. https://doi.org/10.2353/ajpath.2008.070457 (2008).

    Google Scholar 

75. Fang, Q. et al. Dilated cardiomyopathy in transgenic mice expressing HIV Tat. Cardiovasc. Toxicol. 9, 39–45. https://doi.org/10.1007/s12012-009-9035-5 (2009).

    Google Scholar 

76. Currie, P. F. et al. Cardiac autoimmunity in HIV related heart muscle disease. Heart 79, 599–604. https://doi.org/10.1136/hrt.79.6.599 (1998).

    Google Scholar 

77. Clark, E., Nava, B. & Caputi, M. Tat is a multifunctional viral protein that modulates cellular gene expression and functions. Oncotarget 8, 27569–27581. https://doi.org/10.18632/oncotarget.15174 (2017).

    Google Scholar 

78. Wallet, C. et al. Microglial Cells: The Main HIV-1 Reservoir in the Brain. Front. Cell. Infect. Microbiol. 9, 362. https://doi.org/10.3389/fcimb.2019.00362 (2019).

    Google Scholar 

79. Malik, S., Theis, M. & Eugenin, E. A. Connexin43 Containing Gap Junction Channels Facilitate HIV Bystander Toxicity: Implications in NeuroHIV. Front. Mol. Neurosci. 10, 404. https://doi.org/10.3389/fnmol.2017.00404 (2017).

    Google Scholar 

80. Dhawan, S. et al. Human immunodeficiency virus-1-tat protein induces the cell surface expression of endothelial leukocyte adhesion molecule-1, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in human endothelial cells. Blood 90, 1535–1544 (1997).

    Google Scholar 

81. Duan, M. et al. HIV Tat induces expression of ICAM-1 in HUVECs: implications for miR-221/-222 in HIV-associated cardiomyopathy. PLoS One. 8, e60170. https://doi.org/10.1371/journal.pone.0060170 (2013).

    Google Scholar 

82. John, S. A., Kondo, R., Wang, S. Y., Goldhaber, J. I. & Weiss, J. N. Connexin-43 hemichannels opened by metabolic inhibition. J. Biol. Chem. 274, 236–240. https://doi.org/10.1074/jbc.274.1.236 (1999).

    Google Scholar 

83. Velasquez, S. et al. Circulating levels of ATP is a biomarker of HIV cognitive impairment. EBioMedicine 51, 102503. https://doi.org/10.1016/j.ebiom.2019.10.029 (2020).

84. Burridge, P. W., Sharma, A. & Wu, J. C. Genetic and epigenetic regulation of human cardiac reprogramming and differentiation in regenerative medicine. Annu. Rev. Genet. 49, 461–484. https://doi.org/10.1146/annurev-genet-112414-054911 (2015).

    Google Scholar 

85. Burridge, P. W., Keller, G., Gold, J. D. & Wu, J. C. Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell. Stem Cell. 10, 16–28. https://doi.org/10.1016/j.stem.2011.12.013 (2012).

    Google Scholar 

86. Burridge, P. W., Holmström, A. & Wu, J. C. Chemically defined culture and cardiomyocyte differentiation of human pluripotent stem cells. Curr. Protoc. Hum. Genet. 87 (2015).

87. Burridge, P. W. et al. Chemically defined generation of human cardiomyocytes. Nat. Methods. 11, 855–860. https://doi.org/10.1038/nmeth.2999 (2014).

    Google Scholar 

88. Panopoulos, A. D. et al. iPSCORE: A Resource of 222 iPSC Lines Enabling Functional Characterization of Genetic Variation across a Variety of Cell Types. Stem Cell. Rep. 8, 1086–1100. https://doi.org/10.1016/j.stemcr.2017.03.012 (2017).

    Google Scholar 

89. Kilpinen, H. et al. Common genetic variation drives molecular heterogeneity in human iPSCs. Nature 546, 370–375. https://doi.org/10.1038/nature22403 (2017).

    Google Scholar 

90. Ward, M. C., Banovich, N. E., Sarkar, A., Stephens, M. & Gilad, Y. Dynamic effects of genetic variation on gene expression revealed following hypoxic stress in cardiomyocytes. Elife 10. https://doi.org/10.7554/eLife.57345 (2021).

91. Derdeyn, C. A. et al. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J. Virol. 74, 8358–8367. https://doi.org/10.1128/jvi.74.18.8358-8367.2000 (2000).

    Google Scholar 

92. Hauber, J., Perkins, A., Heimer, E. P. & Cullen, B. R. Trans-activation of human immunodeficiency virus gene expression is mediated by nuclear events. Proc. Natl. Acad. Sci. U S A. 84, 6364–6368. https://doi.org/10.1073/pnas.84.18.6364 (1987).

    Google Scholar 

93. Valdebenito, S., Ajasin, D., Prideaux, B. & Eugenin, E. A. Correlative Imaging to Detect Rare HIV Reservoirs and Associated Damage in Tissues. Methods Mol. Biol. 2807, 93–110. https://doi.org/10.1007/978-1-0716-3862-0_7 (2024).

    Google Scholar 

94. Real, F. et al. Platelets from HIV-infected individuals on antiretroviral drug therapy with poor CD4(+) T cell recovery can harbor replication-competent HIV despite viral suppression. Sci. Transl Med. 12 https://doi.org/10.1126/scitranslmed.aat6263 (2020).

95. D’Amico, D. et al. Chronic brain damage in HIV-infected individuals under antiretroviral therapy is associated with viral reservoirs, sulfatide release, and compromised cell-to-cell communication. Cell. Mol. Life Sci. 80, 116. https://doi.org/10.1007/s00018-023-04757-0 (2023).

    Google Scholar 

96. Ajasin, D. & Eugenin, E. Role of Monocyte/Macrophages in the Pathogenesis of NeuroHIV. Results Probl. Cell. Differ. 74, 365–385. https://doi.org/10.1007/978-3-031-65944-7_15 (2024).

    Google Scholar 

97. Contreras, J. E. et al. Metabolic inhibition induces opening of unapposed connexin 43 gap junction hemichannels and reduces gap junctional communication in cortical astrocytes in culture. Proc. Natl. Acad. Sci. U S A. 99, 495–500. https://doi.org/10.1073/pnas.012589799 (2002).

    Google Scholar 

98. Eugenin, E. A., Gonzalez, H., Saez, C. G. & Saez, J. C. Gap junctional communication coordinates vasopressin-induced glycogenolysis in rat hepatocytes. Am. J. Physiol. 274, G1109–1116. https://doi.org/10.1152/ajpgi.1998.274.6.G1109 (1998).

    Google Scholar 

99. Ganor, Y. et al. HIV-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapy. Nat. Microbiol. 4, 633–644. https://doi.org/10.1038/s41564-018-0335-z (2019).

    Google Scholar 

100. Valdebenito, S., Castellano, P., Ajasin, D. & Eugenin, E. A. Astrocytes are HIV reservoirs in the brain: A cell type with poor HIV infectivity and replication but efficient cell-to-cell viral transfer. J. Neurochem. 158, 429–443. https://doi.org/10.1111/jnc.15336 (2021).

     Google Scholar 

101. Leon-Rivera, R. et al. Central nervous system (CNS) viral seeding by mature monocytes and potential therapies to reduce CNS viral reservoirs in the cART era. mBio 12 https://doi.org/10.1128/mBio.03633-20 (2021).

Download references

Supplementary Material 1

Supplementary Material 2

Cite this article

Ajasin, D., Arredondo-Anez, S., Gutierrez, J.A. et al. HIV heart inflammation is mediated by HIV infected myeloid cells, HIV-tat secretion, and aberrant function of Connexin43-containing channels. Sci Rep (2026). https://doi.org/10.1038/s41598-026-43625-2

Download citation

• Received20 July 2025

• Accepted05 March 2026

• Published13 March 2026

• DOIhttps://doi.org/10.1038/s41598-026-43625-2